Cellectar Biosciences
CLRB
CLRB
30 hedge funds and large institutions have $1.52M invested in Cellectar Biosciences in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
95% less capital invested
Capital invested by funds: $30M → $1.52M (-$28.4M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
30
Holding in Top 10
–
Calls
$14K
Puts
$3K
Top Buyers
| 1 | +$156K | |
| 2 | +$112K | |
| 3 | +$47.6K | |
| 4 |
Two Sigma Investments
New York
|
+$21.3K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$12.5K |
Top Sellers
| 1 | -$7.86M | |
| 2 | -$6.84M | |
| 3 | -$5.8M | |
| 4 |
Barclays
London,
United Kingdom
|
-$258K |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$131K |